stockrowEnovis Corporation (ENOV) vs Integra LifeSciences Holdings Corporation (IART)
- Enovis Corporation ENOV 27.33 −4.51%
- Integra LifeSciences Holdings Corporation IART 13.55 −4.04%
Enovis Corporation and Integra LifeSciences Holdings Corporation are both Medical Devices companies. Enovis Corporation is the larger, with a market value of $1.7B against $1.1B — 1.5× the size. Enovis Corporation has negative trailing earnings, so its P/E is not meaningful; Integra LifeSciences Holdings Corporation trades at 83.0×. Enovis Corporation grew revenue faster over the last twelve months: 3.28% against 0.84%. Integra LifeSciences Holdings Corporation has the higher net margin (0.79% vs −22.9%) and the higher return on invested capital (1.79% vs −10.8%). Across the 20 metrics below, Integra LifeSciences Holdings Corporation leads on 13 and Enovis Corporation on 7.
Valuation
Profitability
| Metric | ENOV | IART | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.31% | 52.36% | 57.76% |
| Operating margin | (20.59%) | 4.39% | (15.07%) |
| Net margin | (22.87%) | 0.79% | (14.45%) |
| Free cash flow margin | 3.02% | 5.18% | (3.88%) |
| Return on equity | (29.97%) | 1.24% | (10.35%) |
| Return on assets | (12.91%) | 0.36% | (17.26%) |
| Return on invested capital | (10.83%) | 1.79% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack